BioTalk Unzipped27 Nov 2023

Why Biotech Companies Fail

Biotechnology changes lives, but the stories behind those breakthroughs are often far more complicated than the headlines suggest.

Welcome to the premiere of BioTalk Unzipped, where Gregory Austin and Dr. Chad Briscoe explore the science, people, decisions, failures, and unexpected moments behind medical progress.

In this inaugural episode, Gregory and Chad introduce themselves, explain what drew them into biotechnology and pharmaceutical development, and discuss why they created a podcast designed for scientists and non-scientists alike.

The conversation explores an uncomfortable reality of biotech: even companies built around talented scientists and promising ideas can fail. Gregory and Chad examine what happens when science, capital, execution, and business realities collide, and why setbacks remain an important part of innovation.

Chad also shares some of the biggest surprises from his career in bioanalysis and drug development, while the conversation turns toward what young scientists and industry professionals can do to build successful careers.

BioTalk Unzipped was created to make biotechnology more understandable without stripping away the complexity that makes the field so fascinating.

In this episode

Meet BioTalk Unzipped hosts Gregory Austin and Dr. Chad Briscoe
Why biotechnology companies fail, even when the science looks promising
Unexpected lessons from a career in drug development
What aspiring scientists need to understand about building a career
Why the human stories behind science matter

Connect with the hosts

Gregory Austin

https://www.linkedin.com/in/gregoryaustin1/

Dr. Chad Briscoe

https://www.linkedin.com/in/chadbriscoe/

Gregory Austin’s book, Stellar Resume Writing: Secrets From a Corporate Recruiter:

https://www.amazon.com/dp/B07NTK6RG2

#biotechnology #pharmaceutical #science #drugdevelopment #drugdiscovery

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(45)

Why Gene Therapy Is Still So Hard to Manufacture at Scale | Phillip Ramsey

Why is gene therapy still so difficult to manufacture at scale after decades of progress?Phillip Ramsey, Chief Technical Officer at Sangamo Therapeutics, joins BioTalk Unzipped for a candid conversati...

8 Aug 11min

Her Daughter’s Brain Tumor Turned Her Into a Biotech Founder | Tracy Ryan

A mother’s search for answers to her daughter’s relentless brain tumor led her into natural killer cell biology, cancer immunotherapy, and biotech entrepreneurship.Sponsored by Leucentra, https://leuc...

20 Jul 1h 4min

The Future of Oncology Drug Development | Dr. Lakshmi Amaravadi

Oncology drug development is becoming more complex, and bioanalysis can no longer be treated as simple drug measurement.Sponsored by Leucentra, https://leucentra.com/Inspired by science, empowered by ...

11 Jun 29min

Active Machine Learning for Drug Discovery & Nanomedicine with Dr. Daniel Reker

Can artificial intelligence help make cancer therapies safer, more targeted, and more effective?In this episode of BioTalk Unzipped, Gregory Austin sits down with Dr. Daniel Reker, Assistant Professor...

25 Apr 50min

Why Haven’t We Cured Cancer Yet? | Dr. Bob Liu Explains

Why haven’t we cured cancer yet? A Genentech scientist explains the real reason.In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Bob Liu, Senior Principal Sci...

19 Mar 1h

The Intersection of Biotech, Patent Law, and AI with Dr. Kate Neville, IP Attorney

Recorded October 31, 2025In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Kate Neville, immunologist turned seasoned biotech patent attorney at Marshall, Gers...

16 Feb 52min

Long-acting Cell-Based Gene Therapy, Fabry Disease and Beyond with Glafabra CEO, Dr. Chris Hopkins

In this episode of BioTalk Unzipped, hosts Gregory Austin and Dr. Chad Briscoe sit down with Glafabra CEO: Dr. Chris Hopkins, geneticist, biochemist, and biotech entrepreneur, to explore the science a...

22 Des 202549min

Fail Fast, Learn Faster: Drug Development in Rare Disease with Dr. Binodh DeSilva

In this episode of BioTalk Unzipped, Gregory Austin and Dr. Chad Briscoe sit down with Dr. Binodh DeSilva, Senior Vice President of Bioanalysis at Ultragenyx Pharmaceutical, to explore the science and...

23 Okt 202531min